Table 2.
Indicator | Rationale/what it captures | Source(s) | African coverage |
Publications | Research productivity (as they are the most common form of research results or output38). | Journal databases (eg, Scopus). | Comprehensive—academic journals are well-indexed and typically include country information via institutional affiliations of authors. |
Clinical trials | Indicator of capacity for advanced research. Trials reflect high-cost research investment, conducive research environments and a level of human resources. | WHO’s International Clinical Trials Registry Platform; US National Institutes of Health database (ClinicalTrials.gov). | Comprehensive—all clinical trials are expected to register with one of the main platforms. |
Patents filed | Measures innovation performance. | World Intellectual Property Organization. | Less than half (37%). |
Research institutions | Institutions such as universities, centres of excellence, national institutes of public health or WHO collaborating centres are seen to capture capacity to do HR. | Various. | Various—there are very few platforms that count institutions in a standard way. Some lists exist, but the quality is unclear. |
Research personnel | Human resource capacity to undertake research. | UNESCO Institute for Statistics. | Various. |
Resources for HR | Funds provided to HR from governments or non-state groups are a critical indicator of capacity and level of research activity. | Various. | Various—national government accounts are not standardised. Global R&D data sets have missing data and are not health-specific. |
Policies and regulations | Guidelines, legislation and regulatory institutions can be signs of research activity and a supportive environment. | Various. | Various—no standard indicators or clear sources. |
HR, health research.